News
But even ahead of its release on Tuesday, the book, which covers painful chapters of Didion’s family life that she never divulged publicly, has triggered strong reactions among the writer’s ...
A recent study suggests that sequential intravesical treatment with gemcitabine and docetaxel is more effective than additional bacillus Calmette-Guérin (BCG) therapy for patients with BCG ...
"Knowing that every patient with metastatic prostate cancer who receives a first line of systemic treatment will eventually develop therapy resistance, e.g. against docetaxel or hormones ...
WASHINGTON, DC—Sequential intravesical gemcitabine-docetaxel therapy for patients with nonmuscle-invasive bladder cancer (NMIBC) that is unresponsive to bacillus Calmette-Guérin (BCG ...
Credit: Getty Images Investigators report their early clinical experience using intravesical sequential gemcitabine-docetaxel as first-line therapy for high-risk nonmuscle-invasive bladder cancer.
The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate cancer, can improve the cure rate in these patients. In a new study by ...
The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate cancer, can improve the cure rate in these patients. In a new study ...
Are you taking Docetaxel? Are you aware of the dangers of combining Docetaxel with certain foods and herbs? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and ...
For patients with locally advanced head and neck squamous cell carcinoma who cannot tolerate platinum chemotherapy, docetaxel is a sound alternative to enhance sensitivity to radiotherapy ...
At 12 months, PFS rates were 24.8% with sotorasib compared with 10.1% with docetaxel. Response rates were also significantly higher with sotorasib (28% vs 13%, P<0.001), and more patients ...
For nearly a decade, Toni Matthews-El has published business topics ranging from cloud communication software to best steps for establishing your own LLC. In addition to Forbes Advisor, she's ...
The researchers randomly assigned 78 patients with histologically confirmed advanced NSCLC, regardless of EGFR variants or PD-L1 status, to pembrolizumab in combination with docetaxel (n = 40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results